BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21316111)

  • 1. Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature.
    Würth R; Barbieri F; Bajetto A; Pattarozzi A; Gatti M; Porcile C; Zona G; Ravetti JL; Spaziante R; Florio T
    J Neuroimmunol; 2011 May; 234(1-2):115-23. PubMed ID: 21316111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
    Monnier J; Boissan M; L'Helgoualc'h A; Lacombe ML; Turlin B; Zucman-Rossi J; Théret N; Piquet-Pellorce C; Samson M
    Eur J Cancer; 2012 Jan; 48(1):138-48. PubMed ID: 21778049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.
    Barbieri F; Bajetto A; Dellacasagrande I; Solari A; Würth R; Fernandez V; Rancati S; Ceresa D; Appolloni I; De Luca G; Dono M; Nozza P; Schiapparelli P; Gambaro M; Fiaschi P; Gaggero G; Costanzo N; Thellung S; Malatesta P; Pagano A; Zona G; De Pietri Tonelli D; Florio T
    Neuro Oncol; 2023 Oct; 25(10):1775-1787. PubMed ID: 37074930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
    Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
    Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
    Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
    Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.
    Zabel BA; Lewén S; Berahovich RD; Jaén JC; Schall TJ
    Mol Cancer; 2011 Jun; 10():73. PubMed ID: 21672222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR7 impact on CXCL12 biology and disease.
    Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
    Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
    Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR7 functions as a scavenger for CXCL12 and CXCL11.
    Naumann U; Cameroni E; Pruenster M; Mahabaleshwar H; Raz E; Zerwes HG; Rot A; Thelen M
    PLoS One; 2010 Feb; 5(2):e9175. PubMed ID: 20161793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
    Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
    Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
    Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
    Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
    Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.
    Singh RK; Lokeshwar BL
    Cancer Res; 2011 May; 71(9):3268-77. PubMed ID: 21398406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of CXCR4 and CXCR7 in human endometrial stromal cells is modulated by steroid hormones.
    Zhou WH; Wu X; Hu WD; Du MR
    Int J Clin Exp Pathol; 2015; 8(3):2449-60. PubMed ID: 26045751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.